The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).
 
Aaron Scott Mansfield
Honoraria - Roche
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen (Inst)
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
Other Relationship - Mesothelioma Applied Research Foundation
 
Xiaofei F. Wang
No Relationships to Disclose
 
Dennis A. Wigle
Research Funding - Oncospire Genomics
 
Colleen Watt
No Relationships to Disclose
 
Gregory A. Masters
No Relationships to Disclose
 
Kathryn Kelley
No Relationships to Disclose
 
David E. Kozono
Honoraria - Reflexion Medical
Consulting or Advisory Role - Genentech
 
Tom Stinchcombe
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai/H3 Biomedicine; G1 Therapeutics; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst); Seagen (Inst); Takeda (Inst)